Literature DB >> 1691500

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.

B Motro1, A Itin, L Sachs, E Keshet.   

Abstract

Interleukin 6 (IL-6) is a cytokine that acts on various cell types. Here we show that IL-6 mRNA is produced in vivo in two self-limiting physiologic angiogenic processes: (i) the formation of the vascular system accompanying development of ovarian follicles and (ii) the formation of a capillary network in the maternal decidua following embryonic implantation. In situ and RNA blot hybridization analyses detected transient expression of IL-6 mRNA in gonadotropin-primed hyperstimulated ovaries, with maximal mRNA levels coinciding with the period of formation of a capillary network around follicles. Expression of IL-6 mRNA was detected in the vasculature extending from the ovarian medulla to the forming capillary sheath in the thecal layer of individual growing follicles. No expression was detected in more-developed preovulatory follicles once angiogenesis had been completed. IL-6 mRNA was also detected in the uterus of pregnant mice 9.5 days postcoitum, and there was no appreciable IL-6 mRNA at later stages of embryonic development. Expression in the uterus was confined to cords of endothelial cells in the process of formation of an anastomosing network that traversed the maternal decidua towards the developing embryo. The expression of IL-6 mRNA in two independent physiological angiogenic processes and the transient nature of its expression in endothelial cells suggest a role for IL-6 in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691500      PMCID: PMC53840          DOI: 10.1073/pnas.87.8.3092

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  IL-6. Current research and new questions.

Authors:  I Tamm
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 2.  The molecular regulators of macrophage and granulocyte development. Role of MGI-2/IL-6.

Authors:  L Sachs; J Lotem; Y Shabo
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 3.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

4.  Toward an understanding of angiogenesis: search and discovery.

Authors:  J Folkman
Journal:  Perspect Biol Med       Date:  1985       Impact factor: 1.416

5.  Regulation of expression of interleukin-6. Molecular and clinical studies.

Authors:  A Ray; S B Tatter; U Santhanam; D C Helfgott; L T May; P B Sehgal
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

6.  Mouse IL-6. A hybridoma growth factor with multiple effects on normal B and T cells.

Authors:  J Van Snick; J C Renauld; R J Simpson; C Uyttenhove; A Vink
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

7.  Involvement of IL-6 in mesangial proliferative glomerulonephritis.

Authors:  Y Horii; A Muraguchi; M Iwano; T Matsuda; T Hirayama; H Yamada; Y Fujii; K Dohi; H Ishikawa; Y Ohmoto
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

8.  Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation.

Authors:  L T May; G Torcia; F Cozzolino; A Ray; S B Tatter; U Santhanam; P B Sehgal; D Stern
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

9.  Regulation of megakaryocyte development by interleukin-6.

Authors:  J Lotem; Y Shabo; L Sachs
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

10.  Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta.

Authors:  S S Tabibzadeh; U Santhanam; P B Sehgal; L T May
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

View more
  73 in total

Review 1.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

3.  Engineering macrophages to control the inflammatory response and angiogenesis.

Authors:  K V Eaton; H L Yang; C M Giachelli; M Scatena
Journal:  Exp Cell Res       Date:  2015-11-21       Impact factor: 3.905

4.  Normal and SV40 transfected human peritoneal mesothelial cells produce IL-6 and IL-8: implication for gynaecological disease.

Authors:  X Y Zhang; M Guckian; N Nasiri; P A Lovell; A G Dalgleish; D P J Barton
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.

Authors:  Katarina Engström; Helena Willén; Christina Kåbjörn-Gustafsson; Carola Andersson; Marita Olsson; Melker Göransson; Sofia Järnum; Anita Olofsson; Elisabeth Warnhammar; Pierre Aman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Interleukin-8 stimulates angiogenesis in rats.

Authors:  D E Hu; Y Hori; T P Fan
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

7.  Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.

Authors:  D Shweiki; A Itin; G Neufeld; H Gitay-Goren; E Keshet
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Scatter factor induces blood vessel formation in vivo.

Authors:  D S Grant; H K Kleinman; I D Goldberg; M M Bhargava; B J Nickoloff; J L Kinsella; P Polverini; E M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

Authors:  Gui Young Kwon; Sang Dae Lee; Eon Sub Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

10.  Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy.

Authors:  H Bielefeldt-Ohmann; A L Marzo; R P Himbeck; A G Jarnicki; B W Robinson; D R Fitzpatrick
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.